Symkinet MR

Description

Symkinet MR 10 mg, modified release capsules, hard

Symkinet MR 20 mg, modified release capsules, hard

Symkinet MR 30 mg, modified release capsules, hard

Symkinet MR 40 mg, modified release capsules, hard

Available in packs of 30 modified-release capsules, hard.

Active ingredient: Methylphenidati hydrochloridum

Indications: Symkinet MR is used to treat ‘Attention Deficit Hyperactivity Disorder’ (ADHD).

  • It is used in children and adolescents between the ages of 6 and 18, and in adults.
  • It is used only after treatments which do not involve medicine, such as counselling and behavioural therapy, and which have been insufficient.

 

Additional information

Molecules